Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Lung Cancer (Auckland, N.Z.)|March 16, 2017
Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesAshwin Somasundaram, Timothy F BurnsJournal of Hematology & Oncology|April 25, 2017
The next generation of immunotherapy: keeping lung cancer in checkAshwin Somasundaram, Timothy F BurnsCancer Cell|August 30, 2024
PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancerAshwin Somasundaram, Hanna K SanoffInternational Journal of Molecular Sciences|February 22, 2018
The Role of the Estrogen Pathway in the Tumor MicroenvironmentNatalie J Rothenberger, Ashwin Somasundaram, Laura P StabileDrugs|May 22, 2020
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung CancerAshwin Somasundaram, Mark A Socinski, Liza C VillaruzAdvances in Experimental Medicine and Biology|October 29, 2020
The Impact of Estrogen in the Tumor MicroenvironmentAshwin Somasundaram, Natalie J Rothenberger, Laura P StabileThe Journal of Clinical Investigation|August 19, 2025
KRAS: the Achilles' heel of pancreas cancer biologyKristina Drizyte-Miller, Taiwo Talabi, Ashwin Somasundaram, et al.Trends in Cancer|July 19, 2022
Therapeutic targeting of regulatory T cells in cancerFeng Shan, Ashwin Somasundaram, Tullia C Bruno, et al.Nucleic Acids Research|September 9, 2021
SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulatorsXiaojun Ma, Ashwin Somasundaram, Zengbiao Qi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2022
Fewer LAG-3<sup>+</sup> T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 DiabetesBritta E Jones, Megan D Maerz, Henry T Bahnson, et al.Pageof 3